IRB Study Number 24-1015
Status Recruiting
Institute Endocrinology and Metabolism Institute
Description
This is a cross-sectional study in patients with T1D CKD to test if TIR affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by GLP-1 agonist treatment ex vivo.
Inclusion Criteria
Patients with Type 1 Diabetes with or without chronic kidney disease.
